Cargando…
In vivo imaging of the immune response upon systemic RNA cancer vaccination by FDG-PET
BACKGROUND: [(18)F]Fluoro-2-deoxy-2-d-glucose positron emission tomography (FDG-PET) is commonly used in the clinic for diagnosis of cancer and for follow-up of therapy outcome. Additional to the well-established value in tumor imaging, it bears potential to depict immune processes in modern immunot...
Autores principales: | Pektor, Stefanie, Hilscher, Lina, Walzer, Kerstin C., Miederer, Isabelle, Bausbacher, Nicole, Loquai, Carmen, Schreckenberger, Mathias, Sahin, Ugur, Diken, Mustafa, Miederer, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093825/ https://www.ncbi.nlm.nih.gov/pubmed/30112704 http://dx.doi.org/10.1186/s13550-018-0435-z |
Ejemplares similares
-
Iodine-124 PET quantification of organ-specific delivery and expression of NIS-encoding RNA
por: Miederer, Matthias, et al.
Publicado: (2021) -
Quantification of the Cannabinoid Type 1 Receptor Availability in the Mouse Brain
por: Miederer, Isabelle, et al.
Publicado: (2020) -
PSA and PSA Kinetics Thresholds for the Presence of (68)Ga-PSMA-11 PET/CT-Detectable Lesions in Patients with Biochemical Recurrent Prostate Cancer
por: Hoffmann, Manuela Andrea, et al.
Publicado: (2020) -
Evaluation of the inverse electron demand Diels-Alder reaction in rats using a scandium-44-labelled tetrazine for pretargeted PET imaging
por: Edem, Patricia E., et al.
Publicado: (2019) -
Diagnostic performance of (68)Gallium-PSMA-11 PET/CT to detect significant prostate cancer and comparison with (18)FEC PET/CT
por: Hoffmann, Manuela A., et al.
Publicado: (2017)